Literature DB >> 11326473

Urinary glycosaminoglycans in patients with systemic lupus erythematosus.

P De Muro1, R Faedda, M Formato, F Re, A Satta, G M Cherchi, A Carcassi.   

Abstract

OBJECTIVE: Several investigations indicate that glycosaminoglycans (GAG) are important components of the glomerular basement membrane (GBM) and that they play a remarkable role in the control of charge-selectivity in the glomerular capillary wall. In order to evaluate the possible use of GAG as a marker of glomerular disease, we evaluated urinary GAG excretion in 37 patients with systemic lupus erythematosus (SLE) grouped by disease activity and kidney involvement and in 17 healthy controls.
METHODS: GAG were isolated from urine by using ion-exchange chromatography on DEAE Sephacel. GAG composition was determined by cellulose acetate electrophoresis and expressed as relative percentages by densitometric scanning of Alcian Blue stained strips.
RESULTS: Total GAG levels were significantly increased only in active extra-renal SLE patients. Qualitative analysis of urinary GAG revealed the presence of a low sulphated chondroitin sulphate-protein complex (LSC-PG), whose frequency was higher in patients compared to controls. Moreover, inactive SLE was characterized by an alteration of the chondroitin sulphate/heparan sulphate ratio.
CONCLUSION: These variations suggest the presence of an abnormal permeability of the renal filter in patients without other appreciable signs of kidney alteration. Therefore, qualitative-quantitative urinary GAG analysis could represent an additional diagnostic approach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326473

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.

Authors:  M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Mohamed Tarek; Javier Cáceres Del Carpio; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; Marquis P Vawter; S Michal Jazwinski; Michael V Miceli; Douglas C Wallace; Nitin Udar
Journal:  Biochim Biophys Acta       Date:  2013-11-04

2.  Prediction of urinary protein markers in lupus nephritis.

Authors:  Jim C Oates; Sanju Varghese; Alison M Bland; Timothy P Taylor; Sally E Self; Romesh Stanislaus; Jonas S Almeida; John M Arthur
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

3.  Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG).

Authors:  Pierina De Muro; Rossana Faedda; Antonio Masala; Antonio Junior Lepedda; Elisabetta Zinellu; Milco Ciccarese; Maria Cossu; Pier Giorgio Pala; Rita Pasqualina Satta; Marilena Formato
Journal:  Clin Exp Med       Date:  2012-02-17       Impact factor: 3.984

Review 4.  Advances in glycosaminoglycan detection.

Authors:  Shaukat A Khan; Robert W Mason; Hironori Kobayashi; Seiji Yamaguchi; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2020-03-27       Impact factor: 4.797

5.  Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis.

Authors:  Ilhan Biçer; Kenan Aksu; Zuhal Parildar; Tijen Tanyalçin; Eker Doğanavşargil; Fatma Z Kutay
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

6.  Validation of Urinary Glycosaminoglycans in Iranian patients with Mucopolysaccharidase type I: The effect of urine sedimentation characteristics.

Authors:  Mohammad Abdi; Mohammad Said Hakhamaneshi; Mohammad Reza Alaei; Namam-Ali Azadi; Rahim Vakili; Daniel Zamanfar; Mohammad Taghikhani; Shohreh Khatami
Journal:  Iran J Child Neurol       Date:  2014

7.  Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Pierina De Muro; Antonio Junior Lepedda; Gabriele Nieddu; Michela Idini; Hai Quy Tram Nguyen; Omar Lobina; Pietro Fresu; Marilena Formato
Journal:  Biochem Res Int       Date:  2016-01-24

8.  Urine bikunin as a marker of renal impairment in Fabry's disease.

Authors:  Antonio Junior Lepedda; Laura Fancellu; Elisabetta Zinellu; Pierina De Muro; Gabriele Nieddu; Giovanni Andrea Deiana; Piera Canu; Daniela Concolino; Simona Sestito; Marilena Formato; Gianpietro Sechi
Journal:  Biomed Res Int       Date:  2013-06-12       Impact factor: 3.411

9.  Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes.

Authors:  Antonio Junior Lepedda; Gabriele Nieddu; Silvia Rocchiccioli; Nadia Ucciferri; Michela Idini; Pierina De Muro; Marilena Formato
Journal:  J Diabetes Res       Date:  2018-02-06       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.